MDxHealth (MDXH) Prices 10M ADS Offering at $4/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
MDxHealth Announces Pricing of Offering of ADSs in the United States
February 3, 2023 8:00 AM ESTNEWS RELEASE REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET
MDxHealth Announces Pricing of Offering of ADSsin the United States
IRVINE, CA, and HERSTAL, BELGIUMÂ February 3, 2023 MDxHealth SA (NASDAQ/Euronext: MDXH) (mdxhealth or the Company), a commercial-stage precision diagnostics company, today announced that it has priced a registered public offering of 10,000,000 American Depositary Shares (ADSs) (each representing 10 ordinary shares of the Company without nominal value) (the Offering) at a price... More



